Also from this source

You just read:

Silence Therapeutics' Partner Quark Pharmaceuticals Announces Results From Phase 2 PF-04523655 Study in Diabetic Macular Edema

News provided by

Silence Therapeutics Plc

Mar 21, 2011, 04:09 ET